Our Founder/CEO/CSO, Sareina Wu, will present our work as an invited speaker at the 9th Annual CAR-TCR Summit Europe in London, UK. (February 24-26, 2026)
Speaker:
Sareina Wu, PhD
Chief Executive Officer (GenomeFrontier)
Time:
February 25, 2026 17:25 (GMT+0)
Clinical Data Showcase: Demonstrating Breakthroughs with Clinical Data to Validate Innovation
Presentation topic:
Use of Quantum Engine to Develop Multiplex Dual-Targeting CD19/CD20 CAR-T(SCM) Therapy for B-Cell Malignancies
- Introduce Quantum Engine for non-viral gene therapy
- Describe the benefits of dual-targeting CD19/CD20 T(SCM) cells to overcome antigen escape and improve response durability
- Present preliminary findings from a Phase I open-label trial of GF-CART01 for relapsed or refractory B-cell hematologic cancers
More information: https://cartcr-europe.com/